Detailed eligibility criteria are shown in the Data Supplement (Tables S1 and S2 ... histoscore; IHC, immunohistochemistry; LDR, lymphodepletion regimen; NY-ESO-1, New York esophageal squamous cell ...

Background: Renal cell carcinoma (RCC) is the most common type of kidney cancer ... and viability was calculated using trypan blue (Gibco, 15250-061) staining (Table S2). If the cell viability was ...

Clear cell renal cell carcinoma (ccRCC) is the most prevalent and lethal ... with moderate dysplasia and frequent mitotic figures within the lamina propria. Immunohistochemistry showed positivity for ...

Thomas Hutson, DO, PharmD, discusses key takeaways from the phase 3 CLEAR trial evaluating lenvatinib plus pembrolizumab in patients with advanced renal cell carcinoma.

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

Danés, principal investigator of the Cancer and Stem Cell Biology Lab at the Champalimaud Foundation, in Lisbon, has shown ...

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

Treatment for renal cell carcinoma can vary depending on the size of your tumor, your overall health, how advanced your cancer is, and other factors. Some of the options include surgery, radiation ...

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing ...

non-invasive imaging technique can accurately detect clear-cell renal cell carcinoma, the most common form of kidney ... Sep. 18, 2024 — A team developed a human iPS cell-derived kidney organoid ...